Skip to main content

Diabetes Device News

Diabetes Devices monitor and help to manage your blood sugar levels to try to stay within the target range, helping prevent complications of diabetes.

BGM    CGM     Injection Pens     Insulin Pumps      AID

Dexcom Share – Peace of Mind for Loved Ones, Paving the Way for Next-Gen Mobile CGM.
Twitter Summary: Glucose info right on your wrist? Microsoft/Apple rumored smart watches might make that a reality We first wrote about Google’s venture into the...
Kerri Sparling ( Sixuntilme.com ) discusses CGM in the Cloud, explaining what it is and how it works. Sparling writes about its benefits and drawbacks that are leading...
The Future of Type 1 Diabetes – what challenges and promises lie ahead? Part two of our interview with David Panzirer and Dana Ball.
Changes at the FDA and thoughts on the artificial pancreas!
Snap pumpers can transition to other pump companies at low cost – find out details here.
Plus, a guide to choosing between the six pumps available!
At ADA 2015, Medtronic announced FDA Clearance of MiniMed Connect, a keychain device that sends pump/CGM data via Bluetooth to a smartphone app and enables remote...
What’s next for getting this software to patients?
It seems that the ultimate goal of a GlucoSitter-integrated Medtronic pump would be a 24-hour closed-loop system that requires minimal or no user input (a “fully...
Twitter Summary: Wearing UVA’s DiAs #artificialpancreas in a 3-month study testing overnight and 24-hr closed-loop at home; learnings, surprises, next steps
Larger capacity reservoir will bring pump therapy to those with high insulin needs.
The clinical trial is testing Medtronic’s 670G “hybrid-closed loop” system (insulin pump + Enlite 3 CGM sensor) in people with type 1 diabetes. Based on the Enlite 3 CGM...
Incredible enthusiasm continues for the 14-day sensor that replaces fingersticks.
Google recently received a patent for its glucose-sensing contact lens, providing the first major update we’ve heard on this project since last July. The patent does not...
Why it’s better and when it’s coming to market.
How this new standard paves the way for future artificial pancreas development.
One of the highlights of this year’s ADA Exhibit Hall was NeuroMetrix’s Quell chronic pain management device. Quell is the over the counter version (no prescription...
Submitted to the FDA and could be approved this year.
Twitter summary: mySugr Academy helps people w/ #T2D tame their #diabetes monster in this 10-part video series – first two videos free! mySugr recently released the...

Pages